132 related articles for article (PubMed ID: 36356494)
1. EGFR testing in paraffin-embedded cell block cytology material is reliable with increased detection for effusion fluid.
Man Ng JK; Chow C; Kin Chan RC; Pang Chan K; Xi Li JJ; Ching Li MS; To KF
Lung Cancer; 2022 Dec; 174():97-103. PubMed ID: 36356494
[TBL] [Abstract][Full Text] [Related]
2. Cell HE staining smears and paired cell paraffin sections in detection of epithelial growth factor receptor gene of pleural fluid specimens.
Hou F; Qi C; Lu Y; Li F; Hao Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 47(1):35-44. PubMed ID: 35545361
[TBL] [Abstract][Full Text] [Related]
3. EGFR analysis on scrapings from cytology smears in lung carcinoma, an effective alternative to testing on trucut biopsies.
Mohan AA; Vallonthaiel AG; Nambiar A; Ariyannur P; Joy RA; Thelakkattusserry SK; Vikkath N; Joseph T; Mehta A; Perathur A
Diagn Cytopathol; 2021 Oct; 49(10):1155-1163. PubMed ID: 34432954
[TBL] [Abstract][Full Text] [Related]
4. Molecular Testing for EGFR Mutations and ALK Rearrangements in the Cytological Specimens From the Patients With Non-Small Cell Lung Cancer.
Wang X; Chen S; Emerson RE; Wu HH; Cramer HM; Curless K; Chang HY; Zhang S; Randolph ML; Cheng L
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):119-124. PubMed ID: 30688675
[TBL] [Abstract][Full Text] [Related]
5. [Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].
Sun MH; Yang F; Shen L; Zhang L; Chen Y; Cai X; Zhu XL; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):655-9. PubMed ID: 22321541
[TBL] [Abstract][Full Text] [Related]
6. [Clinical Research of EGFR and KRAS Mutation in Fine Needle Aspiration Cytology Specimens of Non-small Cell Lung Carcinoma].
Zhang Z; Wu X; Ying J; Li J; Qiu T; Guo H; Zhao H; Shan L; Ling Y
Zhongguo Fei Ai Za Zhi; 2015 Apr; 18(4):199-205. PubMed ID: 25936883
[TBL] [Abstract][Full Text] [Related]
7. Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens.
Xu H; Sun W; Zhang G; Cheng Y
J BUON; 2015; 20(1):142-5. PubMed ID: 25778309
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients.
Wu W; Cao Z; Zhang W; Zhang L; Hou L; Wu C
Diagn Pathol; 2020 Jan; 15(1):9. PubMed ID: 32005253
[TBL] [Abstract][Full Text] [Related]
9. EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens.
Billah S; Stewart J; Staerkel G; Chen S; Gong Y; Guo M
Cancer Cytopathol; 2011 Apr; 119(2):111-7. PubMed ID: 21400670
[TBL] [Abstract][Full Text] [Related]
10. Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.
Rafael OC; Aziz M; Raftopoulos H; Vele OE; Xu W; Sugrue C
Cancer Cytopathol; 2014 Jun; 122(6):454-8. PubMed ID: 24723383
[TBL] [Abstract][Full Text] [Related]
11. EGFR, KRAS, BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies.
Forest F; Stachowicz ML; Casteillo F; Karpathiou G; Gouzy-Grosjean F; Guilaubey C; Cottier M; Beal J; Clemenson A; Péoc'h M
Exp Mol Pathol; 2017 Dec; 103(3):306-310. PubMed ID: 29175303
[TBL] [Abstract][Full Text] [Related]
12. EGFR expression as an ancillary tool for diagnosing lung cancer in cytology specimens.
Wei EX; Anga AA; Martin SS; Jackson JG; Nordberg ML; Herrera GA; Turbat-Herrera EA
Mod Pathol; 2007 Sep; 20(9):905-13. PubMed ID: 17643093
[TBL] [Abstract][Full Text] [Related]
13. Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas.
Schneider F; Smith MA; Lane MC; Pantanowitz L; Dacic S; Ohori NP
Am J Clin Pathol; 2015 Feb; 143(2):193-200; quiz 306. PubMed ID: 25596245
[TBL] [Abstract][Full Text] [Related]
14. [Results of EGFR Mutations Detected in Pleural Effusion and Its
Clinical Significance in 132 Patients with Advanced Non-small Cell Lung Cancer:
A Retrospective Study in A Single Center].
Lu T; Li Q; Li L; Yang K; Zhou D; Gao J; Chen M; Xu Y; Zhong W; Wang M; Liang Z; Zhao J
Zhongguo Fei Ai Za Zhi; 2020 Dec; 23(12):1059-1065. PubMed ID: 33357312
[TBL] [Abstract][Full Text] [Related]
15. [Disparities of EGFR mutations between Biopsy and Rebiopsy in Non-small Cell Lung Cancer Patients].
Li H; Yan S; Liu X; Liu Y; Ma L; Wang Y; Liu Y; Cheng Y
Zhongguo Fei Ai Za Zhi; 2018 Nov; 21(11):821-827. PubMed ID: 30454543
[TBL] [Abstract][Full Text] [Related]
16. Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations.
Magnini D; Fuso L; Varone F; D'Argento E; Martini M; Pecoriello A; Di Noia V; Arciuolo D; Fadda G; Rindi G; Richeldi L
Mol Diagn Ther; 2018 Dec; 22(6):723-728. PubMed ID: 30276554
[TBL] [Abstract][Full Text] [Related]
17. Use of Exfoliative Specimens and Fine-Needle Aspiration Smears for Mutation Testing in Lung Adenocarcinoma.
Jain D; Ramachandrappa VS; Singh V; Malik PS; Madan K; Faruq M; Guleria R
Acta Cytol; 2017; 61(6):455-461. PubMed ID: 28848083
[TBL] [Abstract][Full Text] [Related]
18. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.
Ellison G; Zhu G; Moulis A; Dearden S; Speake G; McCormack R
J Clin Pathol; 2013 Feb; 66(2):79-89. PubMed ID: 23172555
[TBL] [Abstract][Full Text] [Related]
19. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
Esterbrook G; Anathhanam S; Plant PK
Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
[TBL] [Abstract][Full Text] [Related]
20. FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.
Treece AL; Montgomery ND; Patel NM; Civalier CJ; Dodd LG; Gulley ML; Booker JK; Weck KE
Cancer Cytopathol; 2016 Jun; 124(6):406-14. PubMed ID: 26882436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
